Not applicableUnknownNCT02000310What this trial is testingMolecular and Cellular Mechanisms of Lysosomal Storage DiseasesWho this might be right forLysosomal Storage Disorders O & O Alpan LLC 80
Testing effectiveness (Phase 2)UnknownNCT03242603What this trial is testingImmunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK CellsWho this might be right forNeuroblastoma Recurrent National University Hospital, Singapore 5
Testing effectiveness (Phase 2)Looking for participantsNCT06026657What this trial is testingGemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8HER2-Negative Breast Carcinoma Margaret Gatti-Mays 42
Not applicableLooking for participantsNCT06539169What this trial is testingFLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesWho this might be right forAlpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more xCures 1,000
Early research (Phase 1)Study completedNCT00743496What this trial is testingA Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and MelanomaWho this might be right forNeuroblastomaMelanomaOsteosarcoma+1 more St. Jude Children's Research Hospital 50
Not applicableNot Yet RecruitingNCT06764537What this trial is testingEvaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in GlioblastomaWho this might be right forGlioblastoma Central Hospital, Nancy, France 18
Early research (Phase 1)Study completedNCT00037011What this trial is testingBeta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic NeuroblastomaWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06450041What this trial is testingNANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) TrialWho this might be right forNeuroblastoma New Approaches to Neuroblastoma Therapy Consortium 62
Testing effectiveness (Phase 2)Study completedNCT00445965What this trial is testingIodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT07523529What this trial is testingBiomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsWho this might be right forAdvanced UnresectableMetastatic Beijing Biotech 72
Testing effectiveness (Phase 2)Looking for participantsNCT07480213What this trial is testingAdaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)Who this might be right forSmall Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage Beijing Biotech 60
Early research (Phase 1)Study completedNCT02761915What this trial is testingA Phase I Trial of Anti-GD2 T-cells (1RG-CART)Who this might be right forRelapsed or Refractory Neuroblastoma Cancer Research UK 17
Not applicableStudy completedNCT05641103What this trial is testingPREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"Who this might be right forGaucher DiseaseAcid SphingoMyelinase DeficiencyASMD+2 more Fundación Española de Hematología y Hemoterapía 122
Testing effectiveness (Phase 2)Looking for participantsNCT07627698What this trial is testingDual-Target CSPG4/GD2 CAR-NK Cells for Advanced MelanomaWho this might be right forUnresectable MelanomaMetastatic Cutaneous MelanomaMetastatic Uveal Melanoma Beijing Biotech 36
Not applicableLooking for participantsNCT06574698What this trial is testingAdding Of Naxitamb In Induction Therapy For High Risk NeuroblastomaWho this might be right forNeuroblastomaGD2 Antibody (Naxitamab) Guangzhou Women and Children's Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT00004184What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) University of Alabama at Birmingham 50
Testing effectiveness (Phase 2)Ended earlyNCT04145037What this trial is testingLentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher DiseaseWho this might be right forGaucher Disease AVROBIO 8
Early research (Phase 1)Study completedNCT00085930What this trial is testingBlood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma PatientsWho this might be right forNeuroblastoma Baylor College of Medicine 19
Testing effectiveness (Phase 2)UnknownNCT04430595What this trial is testingMulti-4SCAR-T Therapy Targeting Breast CancerWho this might be right forBreast Cancer Shenzhen Geno-Immune Medical Institute 100
Very early researchLooking for participantsNCT05620342What this trial is testingAutologous CAR T-Cells Targeting the GD2 Antigen for Lung CancerWho this might be right forLung CancerSmall Cell Lung CarcinomaNon Small Cell Lung Cancer UNC Lineberger Comprehensive Cancer Center 24